Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency

Autor: Fermín Sánchez-Guijo, Jesús María Hernández-Rivas, Jesus M Hernández-Sánchez, Ignacio García-Tuñón, Marta Martín-Izquierdo, Sandra Pérez Ramos, Lucía Méndez, Elena Vuelta, Manuel Sánchez-Martín, Verónica Alonso-Pérez, María de las Nieves Sánchez González de Herrero, Raquel Saldaña, Julián Sevilla
Přispěvatelé: Ministerio de Economía y Competitividad (España), European Commission, Junta de Castilla y León, Fundacion de la Sociedad Española de Hematología y Hemoterapia
Rok vydání: 2019
Předmět:
0301 basic medicine
Embryology
sistemas CRISPR-Cas
Molecular biology
Genetic enhancement
Ataxia Telangiectasia Mutated Proteins
sgRNAs
Synthetic Genome Editing
Genome Engineering
Exon
Gene Knockout Techniques
Mice
Database and Informatics Methods
0302 clinical medicine
Sequencing techniques
CRISPR
DNA sequencing
Proto-Oncogene Proteins c-abl
Frameshift Mutation
Gene Editing
Multidisciplinary
Genome
Mammalian Genomics
Monophenol Monooxygenase
Crispr
línea celular
Exons
Genomics
Null allele
RNA splicing
Medicine
Cell lines
Engineering and Technology
Synthetic Biology
Donor
Nucleotide
Transcriptome Analysis
Sequence Analysis
RNA
Guide
Kinetoplastida

Research Article
Next-Generation Sequencing
Bioinformatics
Science
Bioengineering
Computational biology
Biology
Frameshift mutation
Cell Line
03 medical and health sciences
Gene therapy
Genetics
Cancer Genetics
Animals
Humans
CRISPR/Cas9
Alleles
genoma
2409 Genética
Cas9
Null (mathematics)
Embryos
Biology and Life Sciences
Computational Biology
Oncogenes
Synthetic Genomics
Genome Analysis
Research and analysis methods
030104 developmental biology
Molecular biology techniques
Synthetic Bioengineering
Animal Genomics
Mutation
RNA Splice Sites
CRISPR-Cas Systems
K562 Cells
030217 neurology & neurosurgery
Cloning
Developmental Biology
Zdroj: PLoS ONE
GREDOS: Repositorio Institucional de la Universidad de Salamanca
Universidad de Salamanca (USAL)
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 14, Iss 5, p e0216674 (2019)
GREDOS. Repositorio Institucional de la Universidad de Salamanca
ISSN: 1932-6203
Popis: CRISPR/Cas9 allows the generation of knockout cell lines and null zygotes by inducing site-specific double-stranded breaks. In most cases the DSB is repaired by non-homologous end joining, resulting in small nucleotide insertions or deletions that can be used to construct knockout alleles. However, these mutations do not produce the desired null result in all cases, but instead generate a similar, functionally active protein. This effect could limit the therapeutic efficiency of gene therapy strategies based on abrogating oncogene expression, and therefore needs to be considered carefully. If there is an acceptable degree of efficiency of CRISPR/Cas9 delivery to cells, the key step for success lies in the effectiveness of a specific sgRNA at knocking out the oncogene, when only one sgRNA can be used. This study shows that the null effect could be increased with an sgRNA targeting the splice donor site (SDS) of the chosen exon. Following this strategy, the generation of null alleles would be facilitated in two independent ways: the probability of producing a frameshift mutation and the probability of interrupting the canonical mechanism of pre-mRNA splicing. In these contexts, we propose to improve the loss-of-function yield driving the CRISPR system at the SDS of critical exons.
This work was mainly supported by a grant from the Fondo de Investigaciones Sanitarias (FIS) of the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ERDF) “Una manera de hacer Europa” [grant PI17/01895 to IGT and MSM.]; Junta de Castilla y León, Fondos FEDER [SA085U16 to JMHR]; Novartis grant; and by the Fundación “Jabones para Daniel”. JM Hernández-Sánchez was supported by a research grant from Fundación Española de Hematología y Hemoterapia (FEHH).
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje